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Original Article

Congestive heart failure and sepsis: a retrospective
study of hospitalization outcomes from a rural
hospital in Southwest Missouri
Alexandra Skovrana, Mason Hinkea, Shelly N. B. Sloana, Greg Stahla,b, Kerry Johnsona,c, Scott Goadea,b,
Robert Arncea,b,*
Abstract
Background: Sepsis is the leading cause of death in hospitalized patients and significant effort has been made to facilitate early diag-

nosis and management. However, aggressive treatment can have negative effects, especially in patients with unstable volume status, such
as those with congestive heart failure.
Methods: We used electronic medical records to perform a retrospective study looking at hospital outcomes in patients from Southwest
Missouri who were admitted with sepsis and had a comorbid diagnosis of hypertensive heart failure. Our primary outcome was in-hospital
mortality.
Results: We studied a total of 184 patients with the diagnosis of hypertensive heart failure with sepsis, and 348 patients with the diag-

nosis of sepsis that served as the baseline group. There was a total of 37 (20%) deaths in the hypertensive heart failure group and a total of
94 (27%) deaths in the baseline group.
Conclusion: Our study showed no significant difference between the baseline group and those with hypertensive heart disease with

heart failure.
Keywords: Congestive heart failure, Hypertension, Hypertensive heart disease, Sepsis

cost of approximately 20 billion dollars.[14] This is a devastating disease and its presence should be considered in any patient presenting
with infection. Conversely, unexplained organ damage should prompt
the search for an underlying infection.
Due to the volatile nature of sepsis, several guidelines have been
put in place in an attempt to standardize care and improve mortality
rates. In 2015, the Centers of Medicare and Medicaid Services
(CMS) implemented the Severe Sepsis and Septic Shock Early Management Bundle (SEP-1). This required U.S. hospitals to report compliance rates with core sepsis measures. These requirements involved lactate measurements, fluid resuscitation, and antibiotic coverage. Critics argued that the guidelines were too rigid and did not
allow physicians to individualize care and noted that the difference
in mortality rate was not significant in patients that "failed" (ie,
were not identified and treated in accordance with SEP-1 criteria)
versus those who “passed.”[18]
In 2018, the Society of Critical Care Medicine (SCCM), through
the Surviving Sepsis Campaign (SSC), released an updated guideline
for sepsis treatment known as the hour-1 bundle.[3] This five-step
protocol included (1) measuring a lactate level; (2) drawing blood
cultures; (3) giving broad-spectrum antibiotics; (4) giving fluids;
and (5) vasopressors when appropriate.
This approach is governed by a theoretical acknowledgment of
septic shock as a form of hypovolemic shock with clinical signs of
organ hypoperfusion.[4] Early goaldirected therapy (EGDT) protocol(s) have been accepted as the standard of care for treating patients
with sepsis and septic shock since the early 2000s. Recently, the
3-hour and 6-hour bundles were combined into a single "hour-1
bundle" with intention of resuscitation and management beginning
immediately upon patient presentation.[7] In response to this recommendation, there has been a growing body of scientific and clinical
evidence in support of more conservative fluid management within
EGDT.[4] Furthermore, despite the SSC recommendations, these

Introduction
In 2016, the Society of Critical Care Medicine updated the definition of sepsis to be a life-threatening organ dysfunction due to a dysregulated host response to infection. This new definition was recommended to facilitate earlier recognition and more timely management of patients with sepsis, or those at risk of developing sepsis,
by placing an emphasis on the nonhomeostatic host response.[2,6]
While the true incidence of sepsis is unknown, it is thought to be
the leading cause of mortality and critical illness worldwide and is
the primary cause of death from infection.[2] In the United States,
sepsis is the leading cause of death in hospitalized patients, claiming
220,000 lives in the United States, annually and has a mortality rate
estimated to be between 25% and 50%. Additionally, sepsis is the
single most expensive disease to treat in the hospital with an annual
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Classification of Diseases (ICD)10 code: I11.0 who were hospitalized with a diagnosis of sepsis. We will compare their mortality rate
outcomes with patients who were hospitalized with sepsis only and
see if there is any variability in sepsis outcomes given the presence of
CHF as a comorbidity. We will present the following article in accordance with the Strengthening the Reporting of Observational
studies in Epidemiology (STROBE) checklist.

studies have revealed EGDT as responsible for increasing healthcare costs in patients with sepsis and have been implicated in worsening healthcare outcomes for both adult and pediatric patient
populations.[8–12] Because of this, clinical acknowledgment is
largely based on expert opinion with little-to-no clinical data
supporting improved patient care or outcomes at lengths up to
12 months. Several recent large randomized prospective studies
have provided mounting evidence that aggressive fluid resuscitation is demonstrating harm and poorer outcomes.[4,8–13] New research recommendations have suggested a more conservative fluid
management than the SSC recommendation.[11]
EGDT has been clinically proven to improve short-term mortality in sepsis management. However, with new data being released,
it is also important to look at long-term management. One study
found that positive fluid balance, defined as fluid input greater than
output, was among the strongest prognostic factors for death.[17]
Another study found that patients receiving EGDT often have clinical evidence of fluid overload and an increased incidence of medical
interventions including, thoracentesis and use of diuretics directly
related to fluid overload.[16] Following the release of these guidelines,
several organizing bodies including the American College of Emergency Physicians (ACEP) and the American Academy of Emergency
Medicine (AAEM), issued statements expressing concerns over the
new guidelines. They cited a lack of research and worsening clinical
outcomes as concerns, as well as debating the 1-hour time frame.[19]
Moreover, problems arise when individualized fluid resuscitation treatment plans are not adequately used. Recent studies have shown that
there are in fact 5 distinct phenotypes of septic patients, and proper
treatment is dependent on which class the patient falls in.[21]
Because of the incidence and high mortality rate of sepsis, it is important for clinicians to understand the interplay in sepsis diagnosis
and treatment with comorbid conditions in varying patient populations. Congestive heart failure (CHF) is one of the most prevalent
chronic diseases in the United States. In the United States, 2% of
the population has heart failure, totaling 4.8 million Americans. In
patients aged 65 and over, CHF comprises 20% of all hospitalizations, making it the most common reason for hospital admission.
Furthermore, 30% to 40% of patients with CHF have a history of
hospitalization associated with worse outcomes.[20]
Along with morbidity, there is a significant financial burden on
these patients and the U.S. healthcare system. The annual median
cost for care and hospitalizations of a single patient with CHF is
estimated at $24,383. In 2012, the overall cost globally was estimated at $108 billion.[20] Due to lack of access to comprehensive
care, this burden is likely increased in rural areas. Fortunately, in a
metaanalysis reviewing over 1.5 million cases, they found 1-and
5-year survival rates in patients with CHF are approximately 50%,
which is improved compared to previous decades.[1] This is in large
part due to advances in pharmaceutical and transplant technology.
However, along with this advancement in treatment, there has been
an increase in noncardiovascular death in patients with CHF. Sepsis,
in particular, is a key contributor to mortality in patients with CHF.
The indication for aggressive fluid management in a patient with
CHF presents a complicated clinical course. The fluids must compensate for hypoperfusion without overwhelming the cardiovascular system, thus potentially leading to third-spacing and worsening
pulmonary function. A previous study indicated that septic patients
with a past medical history of CHF received 1 L less of IV fluids on
admission compared to those without a history of CHF with no difference in mortality.[15] Data on whether or not patients met the SSC
hour-1 bundle criteria was collected. This study hopes to expand
further on this topic by looking at patients with the diagnosis of
“Hypertensive Heart Disease with Heart Failure”—International

Methods
Research study design
A retrospective clinical study was designed to investigate outcomes
of septic patients treated at Freeman Hospital in Joplin, MO. This
hospital is one of two major centers in Southwest MO that serves
the four-state area of Oklahoma, Arkansas, Kansas, and Missouri.
By using patients from the same regional area, within the same hospital, we hoped to limit confounding outside factors. Data from
January 1, 2019 to June 27, 2020 was collected via electronic medical records (EMR). Inclusive criteria included a diagnosis of sepsis
for all patients selected using the ICD codes in Table 1. In addition,
for the study group, a diagnosis of hypertensive heart disease with
heart failure, specifically ICD code I11.0 was selected. This ICD
code was chosen because it included the largest patient population
from our data set, which amounted to 184 individuals. In order to
isolate our study group, we excluded ICD codes: 150.31, 150.33,
150.43, 150.23, 150.21, 150.32, 150.42, 150.22, 127.81, I11.0,
I13.0, I13.2, 126.09, 150.9, and 150.20 from the baseline group
(Table 2). This allowed us to reduce the number of patient duplications, as many patients admitted with sepsis had multiple ICD codes
pertaining to heart failure. There were no restrictions in terms of
age, gender, ethnicity, or other health history.

Results
Our baseline group, or patients with sepsis but without the diagnoses listed in Table 2, consisted of 348 people. Within this group,
there were 178 males (52%) and 170 females (48%). Additionally,
264 patients were over the age of 65 (79%), with a mortality rate of
Table 1

ICD-10 Inclusion Criteria for All Patients
ICD-10 Code
A400
A401
A403
A408
A409
A4101
A4102
A411
A412
A413
A414
A4150
A4151
A4152
A4153
A4159
A4181
A4189
A419
R6520
R6521

Diagnosis
Sepsis due to streptococcus, group A
Sepsis due to streptococcus, group B
Sepsis due to Streptococcus pneumonia
Other streptococcal sepsis
Streptococcal sepsis, unspecified
Sepsis due to Methicillin susceptible Staphylococcus aureus
Sepsis due to Methicillin resistant Staphylococcus aureus
Sepsis due to other specified staphylococcus
Sepsis due to unspecified staphylococcus
Sepsis due to Haemophilus influenza
Sepsis due to anaerobes
Gram-negative sepsis, unspecified
Sepsis due to Escherichia coli [E. coli]
Sepsis due to Pseudomonas
Sepsis due to Serratia
Other Gram-negative sepsis
Sepsis due to Enterococcus
Other specified sepsis
Sepsis, unspecified organism
Severe sepsis without septic shock
Severe sepsis with septic shock

ICD, International Classification of Diseases.
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Table 2

Table 4

ICD-10 Codes Excluded in Baseline Group
Diagnosis

Difference in Mortality Rate for Met vs Failed Bundle within
the Baseline and HTN HF Groups

ICD-10 Code

Acute Diastolic Heart Failure
Acute on Chronic Diastolic Heart Failure
Acute on Chronic Systolic and Diastolic Heart Failure
Acute on Chronic Systolic Heart Failure
Acute Systolic Heart Failure
Chronic Diastolic Heart Failure
Chronic Systolic and Diastolic Heart Failure
Chronic Systolic Heart Failure
Cor Pulmonale
HHD and CKD with Heart Failure and Stag1 Through
4 CKD or NOS
HHD with Heart Failure
Pulmonary Embolism NEC with Acute Cor Pulmonale
Right Heart Failure NOS
Systolic Heart Failure NOS

150.31
150.33
150.43
150.23
150.21
150.32
150.42
150.22
127.81
I13.0

Groups

Baseline patient total 348
Baseline patients
65
met bundle
Baseline patients
87
failed bundle
HTN HF patient total 184
HTN HF patients
35
met bundle
HTN HF patients
50
failed bundle

I11.0
126.09
150.9
150.20

Discussion
The purpose of this study was to determine whether heart failure is
associated with worse mortality outcomes in patients with sepsis.
Table 3

Total Mortality Difference between Sepsis Only and Sepsis
with HTN/HF Comorbidity

Total
Female
Male

HTN HF
Patients

HTN HF
Patient
Mortalities

P

348
170
178

94
50
44

184
96
88

37
19
18

0.0788
0.0856
0.4389

170
36

264
46

50
7

44
5

52

35

74

11

14

88
12

96
23

111
26

19
3

18
1

31

19

45

5

9

This was further broken down into the differences in mortality between genders with and without heart failure, between patients that
initially met sepsis bundle criteria and those that did not, and between patients that were over the age of 65 compared to those below
the age of 65.
We did not find any statistically significant results between patients with and without the diagnosis of hypertensive heart disease with heart failure. Unfortunately, the patient sample size
for the bundle criteria groups was not large enough to perform
statistical analyses.
There were several limitations in this study. Given the retrospective nature, data may have been absent for some patients. Additionally, in order to effectively isolate a study group, several ICD codes
were excluded from the final patient population that may have affected data outcomes. Because all data were collected on patients
from a single-center, the outcomes may not be generalizable.
Given the delicate balance between maintaining proper tissue
perfusion in sepsis and attempting to limit the positive fluid balance
associated with worse mortality outcomes in patients with sepsis, further studies should look at CHF as a comorbidity. Specifically, the added difficulties with fluid balance encountered in
this patient population.
Patients were not randomly selected from the population. Therefore, we are uncertain whether the samples are representative of
their respective populations. This study is further limited due to
the inability to completely isolate the effects of heart failure on sepsis. We also acknowledge that there are numerous billing codes for
heart failure. By choosing to focus on "Hypertensive Heart Disease
with Heart Failure" and eliminate patients coded under multiple
heart failure diagnoses, some patients may have been excluded unintentionally Additionally, there are numerous other comorbid conditions that negatively contribute to a patient's prognosis and while
we focused on heart failure, we recognize that other diagnoses can
account for increased mortality. We did not have access to echocardiogram results and were thus unable to break down the stages of
heart failure severity which may play a significant role in CHF's effect on sepsis mortality rates. Data on medications and fluid type or
volume administered was also not collected and we acknowledge
that these could have an impact on renal perfusion and sepsis recovery rates. Unfortunately, we were unable to run any statistical analysis between the groups when we sought to investigate whether the
mortality in HTN/HF septic patients was impacted by SEP-1 Bundle
compliance. Data on bundle compliance was only available for 85
of our 184 patients, and thus comparisons between the 2 groups
were too small for any statistical analysis. Lastly, we chose to focus

30%. Within these groups, there were 94 mortalities (27%), 50 females (30%), and 44 males (25%) (Table 3).
The baseline group was further broken down into those that met
the sepsis bundle criteria and those that failed bundle criteria. Of the
group, 65 patients met the bundle criteria; 29 were males (45%) and
36 were females (55%). Of this cohort, there were 12 mortalities; 7
were females (20%) and 5 were males (17%) (Table 4). There were
87 patients that failed the bundle criteria; 52 were males (60%) and
35 were females (40%). Of the group that failed to meet the bundle
criteria, there were 25 mortalities; 11 were females (31%) and 14
were males (27%) (Table 4).
We identified 184 patients with hypertensive heart disease and heart
failure as a diagnosis for comparison. This group was further broken down
into 88 male patients (48%) and 96 female patients (52%). Within this
group, there were 37 mortalities (20%), 18 males (20%), and 19 females (20%). Additionally, this group contained 111 patients over
the age of 65 (60%) with a specific mortality rate of 30% (Table 4).
We stratified the study group based on whether or not they met
or failed sepsis bundle criteria. There were 35 patients that met the
bundle criteria, 12 male patients (34%) and 23 female patients
(66%), and a total of 4 mortalities—1 male patient (8%) and 3 female patients (13%). On the other hand, 50 patients in the study
group failed to meet sepsis bundle criteria; 31 were men (62%)
and 19 were women (38%). There were 14 mortalities; 9 were
men (64%) and 5 were women (36%) (Table 4).

Baseline
Patient
Mortalities

178
29

HF, heart failure; HTN, hypertension.

CKD, chronic kidney disease; HHD, hypertensive heart disease; ICD, International Classification of Diseases;
NEC, not elsewhere classifiable; NOS, not otherwise specified.

Baseline
Patients

Female
Male
Total Male Female Age 65+ Mortality Mortality

HF, heart failure; HTN, hypertension.
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on mortality as the primary outcome. We deemed this to be the most
valuable indication of treatment success, as it was not possible to directly correlate the length of stay with sepsis resolution.

[4] Marik PE, Byrne L, van Haren F. Fluid resuscitation in sepsis: the great
30 mL per kg hoax. J Thorac Dis. 2020;12(Suppl 1):S37–S47. doi:10.
21037/jtd.2019.12.84
[5] Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the
treatment of severe sepsis and septic shock. N Engl J Med. 2001;345
(19):1368–1377. doi:10.1056/NEJMoa010307
[6] Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign:
International Guidelines for management of sepsis and septic shock: 2016.
Intensive Care Med. 2017;43(3):304–377. doi:10.1007/s00134-017-4683-6
[7] Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign
Bundle: 2018 update. Intensive Care Med. 2018;44(6):925–928. doi:
10.1007/s00134-018-5085-0
[8] PRISM InvestigatorsRowan KM, Angus DC, et al. Early, goal-directed
therapy for septic shock - a patient-level meta-analysis. N Engl J Med.
2017;376(23):2223–2234. doi:10.1056/NEJMoa1701380
[9] ProCESS InvestigatorsYealy DM, Kellum JA, et al. A randomized trial
of protocol-based care for early septic shock. N Engl J Med. 2014;
370(18):1683–1693. doi:10.1056/NEJMoa1401602
[10] ARISE Investigators; ANZICS Clinical Trials GroupPeake SL, et al.
Goal-directed resuscitation for patients with early septic shock. N
Engl J Med. 2014;371(16):1496–1506. doi:10.1056/NEJMoa1404380
[11] Mouncey PR, Osborn TM, Power GS, et al. Protocolised Management
in Sepsis (ProMISe): a multicentre randomised controlled trial of the
clinical effectiveness and cost-effectiveness of early, goal-directed,
protocolised resuscitation for emerging septic shock. NIHR Journals
Library: Southampton (UK); 2015. Accessed November 4, 2021.
https://www.ncbi.nlm.nih.gov/books/NBK327197/
[12] Maitland K, George EC, Evans JA, et al. Exploring mechanisms of
excess mortality with early fluid resuscitation: insights from the
FEAST trial. BMC Med. 2013;11:68. doi:10.1186/1741-7015-11-68
[13] Kalil AC, Johnson DW, Lisco SJ, Sun J. Early goal-directed therapy for sepsis: a
novel solution for discordant survival outcomes in clinical trials. Crit Care Med.
2017;45(4):607–614. doi:10.1097/CCM.0000000000002235
[14] Torio CM, Andrews RM. National Inpatient Hospital Costs: The Most
Expensive Conditions by Payer, 2011. In: Healthcare Cost and Utilization
Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for
Healthcare Research and Quality (US); 2006. Accessed November 10, 2021.
https://www.ncbi.nlm.nih.gov/books/NBK169005/
[15] Franco Palacios CR, Thompson AM, Gorostiaga F. A past medical history of
heart failure is associated with less fluid therapy in septic patients. Antecedentes
de insuficiência cardíaca se associam a tratamento com menor volume de
fluidos em pacientes sépticos. Rev Bras Ter Intensiva. 2019;31(3):340–346.
doi:10.5935/0103-507X.20190049
[16] Kelm DJ, Perrin JT, Cartin-Ceba R, Gajic O, Schenck L, Kennedy CC.
Fluid overload in patients with severe sepsis and septic shock treated
with early goal-directed therapy is associated with increased acute
need for fluid-related medical interventions and hospital death. Shock.
2015;43(1):68–73. doi:10.1097/SHK.0000000000000268
[17] Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care
units: results of the SOAP study. Crit Care Med. 2006;34(2):344–353.
doi:10.1097/01.ccm.0000194725.48928.3a
[18] Rhee C, Filbin MR, Massaro AF, et al. Compliance with the national
SEP-1 quality measure and association with sepsis outcomes: a
multicenter retrospective cohort study. Crit Care Med. 2018;46(10):
1585–1591. doi:10.1097/CCM.0000000000003261
[19] Yealy DM, Mohr NM, Shapiro NI, Venkatesh A, Jones AE, Self WH. Early
care of adults with suspected sepsis in the Emergency Department and out-ofhospital environment: a Consensus-based task force report. Ann Emerg Med.
2021;78(1):1–19. doi:10.1016/j.annemergmed.2021.02.006
[20] Urbich M, Globe G, Pantiri K, et al. A systematic review of medical costs
associated with heart failure in the USA (2014–2020). Pharmacoeconomics.
2020;38(11):1219–1236. doi:10.1007/s40273-020-00952-0
[21] Ma P, Liu J, Shen F, et al. Individualized resuscitation strategy for septic
shock formalized by finite mixture modeling and dynamic treatment
regimen. Crit Care. 2021;25(1):243. doi:10.1186/s13054-021-03682-7

Conclusion
There were no significant differences detected between the baseline
group and the hypertensive heart disease with heart failure group.
This does not mean there are no differences; rather, no significance
was found within this population using the statistical tests we performed. While our hypothesis that CHF as a comorbidity in septic patients would worsen mortality outcomes was not proven statistically,
further studies should investigate the association between the two diseases. A larger population, increased data stratification with heart
failure severity and a more focused look on fluid resuscitation volumes may yield significant results and warrants further investigation.
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